Theoretical and Class-Level Risks These have not been confirmed in cagrilintide trials but are flagged because they appear in related amylin or GLP-1 class data: pancreatitis, gallbladder disease, severe hypoglycemia (mainly when combined with insulin or sulfonylureas), and acute kidney injury secondary to dehydration from severe nausea or vomiting
Side Effects and Safety Considerations GHK-Cu demonstrates an excellent safety profile based on over 40 years of research, though most safety data derives from topical applications and animal studies
Keep a food and skin diary for 46 weeks
At The IV Bar, there are a number of IV drips you can choose from that have been infused with glutathione
For more information, visit novonordisk.com and novonordisk-us.com, and follow us on Facebook, Instagram, X, LinkedIn and YouTube